A 38-year-old woman prcscntcd in March 1991 with a violaceous periorbital rash ( Figure 1) and an erythematous rash on her facc, uppcr trunk, arms, and legs, which was intermittently pruritic. She denied having muscle weakness, myalgias, arthralgias, or dyspnea on exertion. The patient did not have any symptoms involving other organs. On examination, cruptions over the dorsa of hcr hands and Gottron's papules on the knuckles and proximal interphalangeal joints (Figures 2 and 3) wcrc dctcctcd. Proximal and distal musclc strength was normal. Electromyography (EMG) showcd no evidence of an inflammatory myopathy. Thc crcatinc kinasc Icvcl, aldolasc level, crythrocyte sedimentation rate, and C-reactive protein level were all within normal limits. Antinuclear antibodies (ANA) wcrc present at a titer of 1:160 with a speckled pattern. Antibodies to Sm, small nuclcar RNP (snRNP), SS-A, SS-B, doublcstranded DNA (dsDNA), Scl-70, and PM-Scl were all absent.Skin biopsy rcvcaled a superficial perivascular lymphocytic infiltrate with vacuolar interface changes. Necrotic, apoptotic keratinocytes were present along the epidermal basement mernbranc zonc. A slight cpidcrmal hypcrplasia with focal atrophy and compact orthokeratosis were also present. No musclc biopsy was pcrformed bccausc of the lack of specific symptoms. Investigation for a tumor in the lungs, mammae, stomach, and colorectum yielded negative results.
Therapy and clinical courseTherapy with prednisolonc at 40 mgiday was begun, which improved the skin rash rcmarkably. The Submitted for publication July 3, 1995; accepted in revised form March 13, 1996. dosage was tapered to 10 mgiday. During the last 5 years thc following stcroid-sparing agents were administered consecutively, along with the prcdnisolonc: hydroxychloroquinc 100 mgiday, azathioprine 150 mgiday, and dapsone 100 mg/day. However, each time the daily prednisolone dosage was reduced to -6 -1 0 mg, the disease flared; this happened an average of twice per year. Sunscrccns and topical steroids alone did not control the disease. After 4M years of disease, the paticnt does not have any symptoms of muscle weakness or myalgias. She is doing well and participates in sports twice a week.
DiscussionThe symptoms of a violaceous periorbital rash, crythcmatous rash on the face, and Gottron's papules on Figure 1. Erythematous rash and violaceous periorbital rash in the patient, a 38-year old woman.